Jul 23, 2024 / 12:30PM GMT
Operator
Good day and thank you for standing by. Welcome to Kiniksa Pharmaceuticals second-quarter 2024 earnings conference call. (Operator Instructions) Please note that this conference is being recorded.
I will now hand the conference over to your speaker host for today, Rachel Frank, Head of Investor Relations. Please go ahead.
Rachel Frank - Kiniksa Pharmaceuticals Ltd - Head of Investor Relations
Thank you, operator. Good morning, everyone, and thank you for joining Kiniksa's call to discuss our second-quarter 2024 financial results and recent portfolio execution. A press release highlighting these results can be found in our website under the Investors section.
As for the agenda, our Chief Executive Officer, Sanj K. Patel, will start with an introduction. Next Ross Moat, our Chief Commercial Officer, will provide an update on the ARCALYST commercial execution. From there, Mark Ragosa, our Chief Financial Officer, will review our second-quarter 2024 financial results. And finally, Sanj will return for closing remarks and to kick off the Q&A
Q2 2024 Kiniksa Pharmaceuticals Ltd Earnings Call Transcript
Jul 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers